Arcellx, Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065
Mailing Address
800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065
Phone
240-327-0603
Fiscal Year End
1231
EIN
472855917
Financial Overview
FY2025
-$70.69M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 6, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | February 27, 2026 | View on SEC |
| 10-K Annual financial report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 25, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 24, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | February 24, 2026 | View on SEC |
Insider Trading
STRONG SELL
4 insiders
11 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
Kodiak Sciences Inc.
KOD
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.